Efficacy of a rhamnolipid biosurfactant to inhibit Trichophyton rubrum in vitro and in a mice model of dermatophytosis

Exp Dermatol. 2019 May;28(5):601-608. doi: 10.1111/exd.13921.

Abstract

Dermatophytic infections caused by Trichophyton rubrum are the most prevalent superficial mycoses worldwide. The present study was aimed at evaluating the anti-dermatophytic effect of a rhamnolipid biosurfactant (RL) produced by Pseudomonas aeruginosa SS14 (GenBank Accession no. KC866140) against T. rubrum in experimentally induced dermatophytosis in mice models. The purified RL could effectively suppress spore germination and hyphal proliferation of T. rubrum at 500 μg/mL. Ultramicroscopic observations involving SEM and AFM studies revealed severely altered hyphal morphology in the RL-treated mycelia. The membrane disruptive effect of RL was measured by the uptake of propidium iodide (PI) as visualized by CLSM. The absorbance of the RL-treated cell suspension at 260 nm showed concentration-dependant exudation of nucleic acid due to loss of cell membrane integrity. On evaluation of the therapeutic efficacy of RL on experimentally induced cutaneous dermatophytosis in mice models, we observed that the RL, when applied topically at a concentration of 500 μg/mL, was effective in completely curing dermatophytosis at the end of 21-day treatment period. The results were statistically similar to those obtained using the standard drug terbinafine as control. Apart from macroscopic observation, the results were confirmed by culture of skin scrapings and histopathological examination. The results are suggestive of the effectiveness of RL in control of dermatophytosis caused by T. rubrum.

Keywords: antifungal; biosurfactant; dermatophytes; in vivo; ultramicroscopy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology*
  • Cell Proliferation
  • Dermatomycoses / drug therapy*
  • Disease Models, Animal
  • Female
  • Male
  • Mice
  • Microbial Sensitivity Tests
  • Propidium / pharmacology
  • Pseudomonas aeruginosa / chemistry
  • Surface-Active Agents / pharmacology*
  • Tinea / drug therapy*
  • Treatment Outcome
  • Trichophyton / drug effects*

Substances

  • Antifungal Agents
  • Surface-Active Agents
  • Propidium

Associated data

  • GENBANK/KC866140